EndoGastric Solutions: Funding, Investors & Team (Oct 2026)

About EndoGastric Solutions: Based in Redmond, WA, EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company focused on developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD). EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) procedure—a barely invasive solution that addresses a significant unmet clinical need. About Transoral Incisionless Fundoplication (TIF®) procedure for reflux: Performed without the need for external incisions through the skin, the TIF procedure offers patients who require an anatomical repair another treatment option to correct the underlying cause of GERD. Studies show that for up to three years after the TIF procedure esophageal inflammation (esophagitis) is eliminated and most patients are able to stop using daily PPI medications to control symptoms. For current job opportunities please visit http://www.endogastricsolutions.com/careers To locate a physician visit GERDHelp.com. About EsophyX® technology: The original EsophyX device was cleared by the FDA in 2007. EGS launched the third generation EsophyX device, the EsophyX Z in 2015. The technology has continued to evolve and is a clinically-backed tool for physician use in the treatment of GERD. The EsophyX technology now enables surgeons and gastroenterologists to use a wider selection of endoscopes–including low profile and larger high-definition models—to treat the underlying anatomical cause of GERD. The EsophyX technology is used to reconstruct the gastroesophageal valve (GEV) and restore its function as a barrier, preventing stomach acids from washing back up into the esophagus. The device is inserted through the patient’s mouth with direct visual guidance from an endoscope.

EndoGastric Solutions has raised $45.0M across 2 rounds on record. The most recent is an undisclosed round of $18.0M announced in Dec 2022.

EndoGastric Solutions' most recent funding round on record is an undisclosed round of $18.0M, announced in Dec 2022.

Skip Baldino is listed as CEO at EndoGastric Solutions.

EndoGastric Solutions is based in San Mateo, California, United States.

EndoGastric Solutions is in the 51-100 employee band.

EndoGastric Solutions' latest round of $18.0M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.